Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Valvular Heart Disease

Free Subscription Articles published in PLoS One Retrieve available abstracts of 83 articles: HTML format

Single Articles

January 2022
1. LEE JM, Park HB, Song JE, Kim IC, et al
   The impact of cardiopulmonary exercise-derived scoring on prediction of cardio-cerebral outcome in hypertrophic cardiomyopathy.
   PLoS One. 2022;17:e0259638.
   PubMed     Abstract available
   
   
   
2. TONNESSEN TC, Melleby AO, Hauge-Iversen IM, Espe EKS, et al
   Impact of delayed type hypersensitivity arthritis on development of heart failure by aortic constriction in mice.
   PLoS One. 2022;17:e0262821.
   PubMed     Abstract available
   
   
   
3. HULTKVIST H, Nylander E, Tamas E, Svedjeholm R, et al
   Evaluation of left ventricular diastolic function in patients operated for aortic stenosis.
   PLoS One. 2022;17:e0263824.
   PubMed     Abstract available
   
   
   
4. LEE HJ, Kim HK, Lee SC, Ommen SR, et al
   Age-related sex differences in the outcomes of patients with hypertrophic cardiomyopathy.
   PLoS One. 2022;17:e0264580.
   PubMed     Abstract available
   
   
   
5. ZHANG C, Liu J, Qin S
   Prognostic value of cardiac magnetic resonance in patients with aortic stenosis: A systematic review and meta-analysis.
   PLoS One. 2022;17:e0263378.
   PubMed     Abstract available
   
   
   
6. IKOMA T, Naruse Y, Kaneko Y, Sakakibara T, et al
   Pre-procedural predictors of left atrial low-voltage zones in patients undergoing catheter ablation of atrial fibrillation.
   PLoS One. 2022;17:e0266939.
   PubMed     Abstract available
   
   
   January 2021
7. HASEGAWA M, Iwasaki J, Sugiyama S, Ishihara T, et al
   Development of aortic valve stenosis in myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis with renal involvement.
   PLoS One. 2021;16:e0245869.
   PubMed     Abstract available
   
   
   
8. TAYAL B, Malahfji M, Buergler JM, Shah DJ, et al
   Hemodynamic determinants of left atrial strain in patients with hypertrophic cardiomyopathy: A combined echocardiography and CMR study.
   PLoS One. 2021;16:e0245934.
   PubMed     Abstract available
   
   
   
9. WIENER PC, Darwish A, Friend E, Kadem L, et al
   Energy loss associated with in-vitro modeling of mitral annular calcification.
   PLoS One. 2021;16:e0246701.
   PubMed     Abstract available
   
   
   
10. RADBILL AE, Lei LY, Paranjape SY, Blackwell DJ, et al
    Assessment of dynamic cardiac repolarization and contractility in patients with hypertrophic cardiomyopathy.
    PLoS One. 2021;16:e0246768.
    PubMed     Abstract available
    
    
    
11. TANIGUCHI Y, Sakakura K, Nomura Y, Hatori M, et al
    Comparison of long-term outcomes after trans-catheter aortic valve implantation between patients primarily diagnosed by cardiac murmur and those diagnosed by other reasons.
    PLoS One. 2021;16:e0247588.
    PubMed     Abstract available
    
    
    
12. GODLEWSKI K, Dryzek P, Sadurska E, Werner B, et al
    Left ventricular systolic function impairment in children after balloon valvuloplasty for congenital aortic stenosis assessed by 2D speckle tracking echocardiography.
    PLoS One. 2021;16:e0248862.
    PubMed     Abstract available
    
    
    
13. KVASLERUD AB, Santic K, Hussain AI, Auensen A, et al
    Outcomes in asymptomatic, severe aortic stenosis.
    PLoS One. 2021;16:e0249610.
    PubMed     Abstract available
    
    
    
14. PETRYKA-MAZURKIEWICZ J, Ziolkowska L, Mazurkiewicz L, Kowalczyk-Domagala M, et al
    Right-ventricular mechanics assessed by cardiovascular magnetic resonance feature tracking in children with hypertrophic cardiomyopathy.
    PLoS One. 2021;16:e0248725.
    PubMed     Abstract available
    
    
    
15. HAMMER Y, Talmor-Barkan Y, Abelow A, Orvin K, et al
    Myocardial extracellular volume quantification by computed tomography predicts outcomes in patients with severe aortic stenosis.
    PLoS One. 2021;16:e0248306.
    PubMed     Abstract available
    
    
    
16. ROY D, Mazumder O, Sinha A, Khandelwal S, et al
    Multimodal cardiovascular model for hemodynamic analysis: Simulation study on mitral valve disorders.
    PLoS One. 2021;16:e0247921.
    PubMed     Abstract available
    
    
    
17. CHOUAIRI F, Mullan CW, Sen S, Mori M, et al
    Impact of the new heart allocation policy on patients with restrictive, hypertrophic, or congenital cardiomyopathies.
    PLoS One. 2021;16:e0247789.
    PubMed     Abstract available
    
    
    
18. KUSNER J, Luraghi G, Khodaee F, Rodriguez Matas JF, et al
    Understanding TAVR device expansion as it relates to morphology of the bicuspid aortic valve: A simulation study.
    PLoS One. 2021;16:e0251579.
    PubMed     Abstract available
    
    
    
19. WILLITS I, Keltie K, de Belder M, Henderson R, et al
    Safety, effectiveness and costs of percutaneous mitral valve repair: A real-world prospective study.
    PLoS One. 2021;16:e0251463.
    PubMed     Abstract available
    
    
    
20. LEMES DA SILVA MV, Nunes Filho ACB, Rosa VEE, Caixeta A, et al
    Improvement of renal function after transcatheter aortic valve replacement in patients with chronic kidney disease.
    PLoS One. 2021;16:e0251066.
    PubMed     Abstract available
    
    
    
21. AYME-DIETRICH E, Da Silva S, Bouabout GA, Arnoux A, et al
    Characterization of the spontaneous degenerative mitral valve disease in FVB mice.
    PLoS One. 2021;16:e0257022.
    PubMed     Abstract available
    
    
    
22. NASCIUTTI PR, Moraes AT, Santos TK, Goncalves Queiroz KK, et al
    Protective effects of omega-3 fatty acids in dogs with myxomatous mitral valve disease stages B2 and C.
    PLoS One. 2021;16:e0254887.
    PubMed     Abstract available
    
    
    
23. LIAW J, Walker B, Hall L, Gorton S, et al
    Rheumatic heart disease in pregnancy and neonatal outcomes: A systematic review and meta-analysis.
    PLoS One. 2021;16:e0253581.
    PubMed     Abstract available
    
    
    
24. WEFERLING M, Liebetrau C, Renker M, Fischer-Rasokat U, et al
    Right bundle branch block is not associated with worse short- and mid-term outcome after transcatheter aortic valve implantation.
    PLoS One. 2021;16:e0253332.
    PubMed     Abstract available
    
    
    
25. RIENGVIRODKIJ N, Roytrakul S, Jaresitthikunchai J, Phaonakrop N, et al
    Peptide barcodes in dogs affected by mitral valve disease with and without pulmonary hypertension using MALDI-TOF MS and LC-MS/MS.
    PLoS One. 2021;16:e0255611.
    PubMed     Abstract available
    
    
    
26. ABU KHADIJA H, Gandelman G, Ayyad O, Jaber M, et al
    Differential systemic inflammatory responses after TAVI: The role of self versus balloon expandable devices.
    PLoS One. 2021;16:e0258963.
    PubMed     Abstract available
    
    
    
27. YAMAWAKI M, Honda Y, Makino K, Nakano T, et al
    Influence of polyvascular disease on clinical outcome in patients undergoing transcatheter aortic valve implantation via transfemoral access.
    PLoS One. 2021;16:e0260385.
    PubMed     Abstract available
    
    
    
28. DA SILVA TL JR, Pazin-Filho A, Romano MMD, Ferriani VPL, et al
    Mitral valve thickening in acute rheumatic fever as a predictor of late valvar dysfunction.
    PLoS One. 2021;16:e0259737.
    PubMed     Abstract available
    
    
    January 2020
29. SEMAKULA JR, Mouton JP, Jorgensen A, Hutchinson C, et al
    A cross-sectional evaluation of five warfarin anticoagulation services in Uganda and South Africa.
    PLoS One. 2020;15:e0227458.
    PubMed     Abstract available
    
    
    
30. KIM D, Shim CY, Hong GR, Jeong H, et al
    Morphological and functional characteristics of mitral annular calcification and their relationship to stroke.
    PLoS One. 2020;15:e0227753.
    PubMed     Abstract available
    
    
    
31. GUGLIELMINI C, Toaldo MB, Chiesa A, Contiero B, et al
    Effect of temperature variation on hospital admissions and outcomes in dogs with myxomatous mitral valve disease and new onset pulmonary edema.
    PLoS One. 2020;15:e0227807.
    PubMed     Abstract available
    
    
    
32. MOON I, Lee SY, Kim HK, Han KD, et al
    Trends of the prevalence and incidence of hypertrophic cardiomyopathy in Korea: A nationwide population-based cohort study.
    PLoS One. 2020;15:e0227012.
    PubMed     Abstract available
    
    
    
33. VENNEMANN B, Obrist D, Rosgen T
    A smartphone-enabled wireless and batteryless implantable blood flow sensor for remote monitoring of prosthetic heart valve function.
    PLoS One. 2020;15:e0227372.
    PubMed     Abstract available
    
    
    
34. MIURA S, Inoue K, Kumamaru H, Yamashita T, et al
    Clinical impact of pathology-proven etiology of severely stenotic aortic valves on mid-term outcomes in patients undergoing surgical aortic valve replacement.
    PLoS One. 2020;15:e0229721.
    PubMed     Abstract available
    
    
    
35. OWASHI KP, Hubert A, Galli E, Donal E, et al
    Model-based estimation of left ventricular pressure and myocardial work in aortic stenosis.
    PLoS One. 2020;15:e0229609.
    PubMed     Abstract available
    
    
    
36. XU L, Chen X, Cui M, Ren C, et al
    The improvement of the shear stress and oscillatory shear index of coronary arteries during Enhanced External Counterpulsation in patients with coronary heart disease.
    PLoS One. 2020;15:e0230144.
    PubMed     Abstract available
    
    
    
37. PALUMBO MC, Rong LQ, Kim J, Navid P, et al
    Prosthetic aortic graft replacement of the ascending thoracic aorta alters biomechanics of the native descending aorta as assessed by transthoracic echocardiography.
    PLoS One. 2020;15:e0230208.
    PubMed     Abstract available
    
    
    
38. HABERMAN D, Chernin G, Meledin V, Zikry M, et al
    Urea level is an independent predictor of mortality in patients with severe aortic valve stenosis.
    PLoS One. 2020;15:e0230002.
    PubMed     Abstract available
    
    
    
39. HARDT F, Becker M, Brandenburg V, Grebe J, et al
    Impact of epicardial adipose tissue volume upon left ventricular dysfunction in patients with mild-to-moderate aortic stenosis: A post-hoc analysis.
    PLoS One. 2020;15:e0229636.
    PubMed     Abstract available
    
    
    
40. GITTENBERGER-DE GROOT AC, Peterson JC, Wisse LJ, Roest AAW, et al
    Pulmonary ductal coarctation and left pulmonary artery interruption; pathology and role of neural crest and second heart field during development.
    PLoS One. 2020;15:e0228478.
    PubMed     Abstract available
    
    
    
41. PAULUS MG, Meindl C, Bohm L, Holzapfel M, et al
    Predictors of functional improvement in the short term after MitraClip implantation in patients with secondary mitral regurgitation.
    PLoS One. 2020;15:e0232817.
    PubMed     Abstract available
    
    
    
42. LARUPA SANTOS J, Rodriguez I, S Olesen M, Hjorth Bentzen B, et al
    Investigating gene-microRNA networks in atrial fibrillation patients with mitral valve regurgitation.
    PLoS One. 2020;15:e0232719.
    PubMed     Abstract available
    
    
    
43. NIJENKAMP LLAM, Bollen IAE, Niessen HWM, Dos Remedios CG, et al
    Sex-specific cardiac remodeling in early and advanced stages of hypertrophic cardiomyopathy.
    PLoS One. 2020;15:e0232427.
    PubMed     Abstract available
    
    
    
44. EL-REWAIDY H, Neisius U, Nakamori S, Ngo L, et al
    Characterization of interstitial diffuse fibrosis patterns using texture analysis of myocardial native T1 mapping.
    PLoS One. 2020;15:e0233694.
    PubMed     Abstract available
    
    
    
45. LI Q, Laflamme DP, Bauer JE
    Serum untargeted metabolomic changes in response to diet intervention in dogs with preclinical myxomatous mitral valve disease.
    PLoS One. 2020;15:e0234404.
    PubMed     Abstract available
    
    
    
46. SEO J, Kim DY, Cho I, Hong GR, et al
    Prevalence, predictors, and prognosis of tricuspid regurgitation following permanent pacemaker implantation.
    PLoS One. 2020;15:e0235230.
    PubMed     Abstract available
    
    
    
47. BRAMBILLA PG, Polli M, Pradelli D, Papa M, et al
    Epidemiological study of congenital heart diseases in dogs: Prevalence, popularity, and volatility throughout twenty years of clinical practice.
    PLoS One. 2020;15:e0230160.
    PubMed     Abstract available
    
    
    
48. OZTURK C, Becher MU, Kalkan A, Kavsur R, et al
    The modified MIDA-Score predicts mid-term outcomes after interventional therapy of functional mitral regurgitation.
    PLoS One. 2020;15:e0236265.
    PubMed     Abstract available
    
    
    
49. CHANG MC, Wu MT, Weng KP, Chien KJ, et al
    Biventricular myocardial adaptation in patients with repaired tetralogy of Fallot: Mechanistic insights from magnetic resonance imaging tissue phase mapping.
    PLoS One. 2020;15:e0237193.
    PubMed     Abstract available
    
    
    
50. TRINDADE F, Saraiva F, Keane S, Leite-Moreira A, et al
    Preoperative myocardial expression of E3 ubiquitin ligases in aortic stenosis patients undergoing valve replacement and their association to postoperative hypertrophy.
    PLoS One. 2020;15:e0237000.
    PubMed     Abstract available
    
    
    
51. FEUILLATRE H, Auffret V, Castro M, Lalys F, et al
    Similarity measures and attribute selection for case-based reasoning in transcatheter aortic valve implantation.
    PLoS One. 2020;15:e0238463.
    PubMed     Abstract available
    
    
    
52. VALENTE C, Guglielmini C, Domenech O, Contiero B, et al
    Symmetric dimethylarginine in dogs with myxomatous mitral valve disease at various stages of disease severity.
    PLoS One. 2020;15:e0238440.
    PubMed     Abstract available
    
    
    
53. JAAKKOLA J, Jaakkola S, Airaksinen KEJ, Husso A, et al
    Subtype of atrial fibrillation and the outcome of transcatheter aortic valve replacement: The FinnValve Study.
    PLoS One. 2020;15:e0238953.
    PubMed     Abstract available
    
    
    
54. AL-SHAMMARI H, Latif N, Sarathchandra P, McCormack A, et al
    Expression and function of mechanosensitive ion channels in human valve interstitial cells.
    PLoS One. 2020;15:e0240532.
    PubMed     Abstract available
    
    
    
55. OKAMOTO R, Goto I, Nishimura Y, Kobayashi I, et al
    Gap junction protein beta 4 plays an important role in cardiac function in humans, rodents, and zebrafish.
    PLoS One. 2020;15:e0240129.
    PubMed     Abstract available
    
    
    
56. PEVERILL RE, Chou B, Donelan L, Thai WE, et al
    Left ventricular long-axis function in hypertrophic cardiomyopathy - Relationships between e`, early diastolic excursion and duration, and systolic excursion.
    PLoS One. 2020;15:e0240296.
    PubMed     Abstract available
    
    
    
57. JOLL JE 2ND, Clark CR, Peters CS, Raddatz MA, et al
    Genetic ablation of serotonin receptor 2B improves aortic valve hemodynamics of Notch1 heterozygous mice in a high-cholesterol diet model.
    PLoS One. 2020;15:e0238407.
    PubMed     Abstract available
    
    
    
58. AL HAGEH C, Rahy R, Khazen G, Brial F, et al
    Plasma and urine metabolomic analyses in aortic valve stenosis reveal shared and biofluid-specific changes in metabolite levels.
    PLoS One. 2020;15:e0242019.
    PubMed     Abstract available
    
    
    
59. ARMOIRY X, Obadia JF, Auguste P, Connock M, et al
    Conflicting findings between the Mitra-Fr and the Coapt trials: Implications regarding the cost-effectiveness of percutaneous repair for heart failure patients with severe secondary mitral regurgitation.
    PLoS One. 2020;15:e0241361.
    PubMed     Abstract available
    
    
    
60. MINO T, Kimura S, Kitaura A, Iwamoto T, et al
    Can left ventricular hypertrophy on electrocardiography detect severe aortic valve stenosis?
    PLoS One. 2020;15:e0241591.
    PubMed     Abstract available
    
    
    
61. ROH SY, Choi JI, Kim MS, Cho EY, et al
    Incidence and etiology of sudden cardiac arrest in Koreans: A cohort from the national health insurance service database.
    PLoS One. 2020;15:e0242799.
    PubMed     Abstract available
    
    
    January 2019
62. MAYR NP, Wiesner G, Kretschmer A, Bronner J, et al
    Assessing the level of radiation experienced by anesthesiologists during transfemoral Transcatheter Aortic Valve Implantation and protection by a lead cap.
    PLoS One. 2019;14:e0210872.
    PubMed     Abstract available
    
    
    
63. CZIMBALMOS C, Csecs I, Toth A, Kiss O, et al
    The demanding grey zone: Sport indices by cardiac magnetic resonance imaging differentiate hypertrophic cardiomyopathy from athlete's heart.
    PLoS One. 2019;14:e0211624.
    PubMed     Abstract available
    
    
    
64. SUNG SH, Lee CW, Wang PN, Lee HY, et al
    Cognitive functions and jugular venous reflux in severe mitral regurgitation: A pilot study.
    PLoS One. 2019;14:e0207832.
    PubMed     Abstract available
    
    
    
65. NOMURA K, Ajiro Y, Nakano S, Matsushima M, et al
    Characteristics of mitral valve leaflet length in patients with pectus excavatum: A single center cross-sectional study.
    PLoS One. 2019;14:e0212165.
    PubMed     Abstract available
    
    
    
66. ZHAO M, Liu M, Leal JP, Tsui BMW, et al
    Association of PET-measured myocardial flow reserve with echocardiography-estimated pulmonary artery systolic pressure in patients with hypertrophic cardiomyopathy.
    PLoS One. 2019;14:e0212573.
    PubMed     Abstract available
    
    
    
67. STEINMETZ M, Schmitter C, Radecke T, Stundl A, et al
    Brief report - Telomere length is a poor biomarker to predict 1-year mortality or cardiovascular comorbidity in patients with transcatheter aortic valve replacement.
    PLoS One. 2019;14:e0213250.
    PubMed     Abstract available
    
    
    
68. KNY M, Csalyi KD, Klaeske K, Busch K, et al
    Ninjurin1 regulates striated muscle growth and differentiation.
    PLoS One. 2019;14:e0216987.
    PubMed     Abstract available
    
    
    
69. MILLER RJH, Heidary S, Pavlovic A, Schlachter A, et al
    Defining genotype-phenotype relationships in patients with hypertrophic cardiomyopathy using cardiovascular magnetic resonance imaging.
    PLoS One. 2019;14:e0217612.
    PubMed     Abstract available
    
    
    
70. STUNDL A, Lucht H, Shamekhi J, Weber M, et al
    Early versus newer generation transcatheter heart valves for transcatheter aortic valve implantation: Echocardiographic and hemodynamic evaluation of an all-comers study cohort using the dimensionless aortic regurgitation index (AR-index).
    PLoS One. 2019;14:e0217544.
    PubMed     Abstract available
    
    
    
71. CHRISTENSEN NL, Dahl JS, Carter-Storch R, Jensen K, et al
    Association between left ventricular diastolic function and right ventricular function and morphology in asymptomatic aortic stenosis.
    PLoS One. 2019;14:e0215364.
    PubMed     Abstract available
    
    
    
72. DE LANGE MMA, Scheepmaker A, van der Hoek W, Leclercq M, et al
    Risk of chronic Q fever in patients with cardiac valvulopathy, seven years after a large epidemic in the Netherlands.
    PLoS One. 2019;14:e0221247.
    PubMed     Abstract available
    
    
    
73. NEISIUS U, Myerson L, Fahmy AS, Nakamori S, et al
    Cardiovascular magnetic resonance feature tracking strain analysis for discrimination between hypertensive heart disease and hypertrophic cardiomyopathy.
    PLoS One. 2019;14:e0221061.
    PubMed     Abstract available
    
    
    
74. TAN K, Markby G, Muirhead R, Blake R, et al
    Evaluation of canine 2D cell cultures as models of myxomatous mitral valve degeneration.
    PLoS One. 2019;14:e0221126.
    PubMed     Abstract available
    
    
    
75. ZHANG Y, Wang VY, Morgan AE, Kim J, et al
    Mechanical effects of MitraClip on leaflet stress and myocardial strain in functional mitral regurgitation - A finite element modeling study.
    PLoS One. 2019;14:e0223472.
    PubMed     Abstract available
    
    
    
76. IWANUK N, Wall L, Nolte I, Raue J, et al
    Effect of pimobendan on physical fitness, lactate and echocardiographic parameters in dogs with preclinical mitral valve disease without cardiomegaly.
    PLoS One. 2019;14:e0223164.
    PubMed     Abstract available
    
    
    
77. TAKEJI Y, Taniguchi T, Morimoto T, Saito N, et al
    Transcatheter aortic valve implantation versus conservative management for severe aortic stenosis in real clinical practice.
    PLoS One. 2019;14:e0222979.
    PubMed     Abstract available
    
    
    
78. SCHAHAB N, Fimmers R, Mahn T, Schaefer C, et al
    Comparative study of pressure (ankle-brachial pressure index) and flow (strain gauge plethysmography and reactive hyperaemia) measurements in diagnosis of peripheral arterial disease in patients with severe aortic stenosis.
    PLoS One. 2019;14:e0220510.
    PubMed     Abstract available
    
    
    
79. FANG F, Tang J, Zhao Y, He J, et al
    Transcatheter aortic valve implantation versus surgical aortic valve replacement in patients at low and intermediate risk: A risk specific meta-analysis of randomized controlled trials.
    PLoS One. 2019;14:e0221922.
    PubMed     Abstract available
    
    
    
80. WANG G, Rao N, Liu D, Jiang H, et al
    Analysis of potential roles of combinatorial microRNA regulation in occurrence of valvular heart disease with atrial fibrillation based on computational evidences.
    PLoS One. 2019;14:e0221900.
    PubMed     Abstract available
    
    
    
81. FISCHER-RASOKAT U, Renker M, Liebetrau C, Weferling M, et al
    Outcome of patients with heart failure after transcatheter aortic valve implantation.
    PLoS One. 2019;14:e0225473.
    PubMed     Abstract available
    
    
    
82. TANAKA M, Yanagisawa R, Yashima F, Arai T, et al
    Previously implanted mitral surgical prosthesis in patients undergoing transcatheter aortic valve implantation: Procedural outcome and morphologic assessment using multidetector computed tomography.
    PLoS One. 2019;14:e0226512.
    PubMed     Abstract available
    
    
    
83. DE-MIGUEL-DIEZ J, Lopez-de-Andres A, Hernandez-Barrera V, De Miguel-Yanes JM, et al
    Trends, characteristics, in-hospital outcomes and mortality in surgical mitral valve replacement among patients with and without COPD in Spain (2001-2015).
    PLoS One. 2019;14:e0221263.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Valvular Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: